Mark D. Booth
2014
In 2014, Mark D. Booth earned a total compensation of $1.6M as Chief Commercial Officer outgoing at Orexigen Therapeutics, a 25% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $178,248 |
|---|---|
| Option Awards | $1,040,191 |
| Salary | $379,250 |
| Other | $8,316 |
| Total | $1,606,005 |
Booth received $1M in option awards, accounting for 65% of the total pay in 2014.
Booth also received $178.2K in non-equity incentive plan, $379.3K in salary and $8.3K in other compensation.
Rankings
In 2014, Mark D. Booth's compensation ranked 5,462nd out of 13,032 executives tracked by ExecPay. In other words, Booth earned more than 58.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,462 out of 13,032 | 58th |
Division Manufacturing | 1,953 out of 4,966 | 61st |
Major group Chemicals And Allied Products | 660 out of 1,686 | 61st |
Industry group Drugs | 510 out of 1,365 | 63rd |
Industry Pharmaceutical Preparations | 399 out of 1,043 | 62nd |
Source: SEC filing on April 22, 2015.
Booth's colleagues
We found four more compensation records of executives who worked with Mark D. Booth at Orexigen Therapeutics in 2014.
2014
Michael Narachi
Orexigen Therapeutics
Chief Executive Officer
2014
Joseph Hagan
Orexigen Therapeutics
Former Chief Business and Financial Officer
2014
Heather Turner
Orexigen Therapeutics
General Counsel
2014
Preston Klassen
Orexigen Therapeutics